AURA
AURA clinical trials: Aura Biosciences, Inc.
Every trial on ClinicalTrials.gov where Aura Biosciences, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 10
- Trials linked
- 10
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
AURA on the catalyst calendar · AURA registry changes
- Primary completion Aug 15, 2028Sponsor estimateNo phase registeredNCT07421739Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) SubjectsAura Biosciences · Choroidal MelanomaActive, not recruitingAURALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 15, 2027Sponsor estimatePhase 3NCT06007690A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to...Aura Biosciences · Choroidal MelanomaActive, not recruitingAURALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2026Sponsor estimatePhase 2NCT06643884Suprachoroidal Administration in Subjects With Metastases to the ChoroidAura Biosciences · Eye CancerRecruitingAURALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 15, 2033Sponsor estimateNo phase registeredNCT07338968A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal MelanomaAura Biosciences · Choroidal MelanomaEnrolling by invitationAURALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2027Sponsor estimatePhase 1NCT05483868A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder CancerAura Biosciences · Non-muscle-invasive Bladder CancerActive, not recruitingAURALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2028Sponsor estimateNo phase registeredNCT03941379A Registry of Subjects With Primary Indeterminate Lesions or Choroidal MelanomaAura Biosciences · Choroidal MelanomaActive, not recruitingAURALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 13, 2026ActualNo phase registeredNCT06664944Technology Exposure and Child Health: Wellness Impact and Social Effects: An Observational Product Registry StudyAura · MoodCompletedAURALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 22, 2024ActualPhase 2NCT04417530Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate...Aura Biosciences · Uveal MelanomaCompletedAURALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 26, 2021ActualPhase 1/Phase 2NCT03052127Study in Subjects With Small Primary Choroidal MelanomaAura Biosciences · Uveal MelanomaCompletedAURALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 1, 2023ActualNo phase registeredNCT05266430Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions...Aura Biosciences · Choroidal MelanomaTerminatedAURALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 10 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner